- Enabled Products
- Enabling Products
Synthetic Biology Market size was valued at USD 9.4 billion in 2023 and is expected to reach USD 47.4 billion by 2029, at a CAGR of 26% from 2024-2030. Synthetic biology is a new interdisciplinary area of the medical field that involves the application of engineering principles in biology. Synthetic biology combines various disciplines within both domains such as genetic engineering, biotechnology, molecular engineering biophysics, computer engineering, electrical engineering and other various branches for the development of artificial biological systems for research engineering and medical applications.
The design and building of new biological parts, equipment, and systems, as well as the re-design of existing, natural biological systems for practical purposes, are all examples of synthetic biology. Furthermore, it has various applications in industrial enzymes, vaccines and antibody production, bio-based chemicals as well as synthetic biological life science research. Synthetic biology is an evolutionary segment of medical technology and market is in the developing stage. Market players and researchers are actively participating in R&D activities to develop and introduce the revolutionary technologies. Furthermore, government funding and support for the research fuelling the market growth. Pharmaceutical and biotechnology businesses spend a lot of money on research in order to produce breakthrough compounds that will meet the rising needs of the healthcare industry and fight new ailments. Collaboration and acquisitions are key strategies adopted by the market players to boost their market revenue share in synthetic biology market.
Synthetic Biology Market Key Developments:
- In March 2015, Synpromics Limited, collaborated with iniQure N.V. to develop synthetic promoters with a specific application in the delivery of gene medicines to the liver.
- In January 2017, Ginkgo Bioworks, a microorganism company acquired a provider of synthetic DNA Gen9. By this acquisition, company seeks to improve its speed and capacity in constructing new organism design for use across the multiple industries
Synthetic Biology Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
26%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Synthetic Biology Market Dynamics
Synthetic biology market is driven by the rapid increase in R&D investments in synthetic biology and adaptation of genetically engineered products and DNA sequencing for the treatment and understanding of the diseases progress. In addition, increase in funding from government in life science research and development and advancements in molecular biology expected to boost the synthetic biology during the forecast period. Furthermore, private institutional contribution to synthetic biology research expected to push the market growth. However, lack of regulatory framework, biosafety and biosecurity issues coupled with government policies may hinder the synthetic biology market growth over the forecast period.
North-America Got Significant Share of
Synthetic Biology Market Regional Analysis
North America dominates the market region for Synthetic Biology Market. A significant portion can be attributed to rising investment in private businesses, advantageous rules, and government support. In order to fuel the expansion of the synthetic biology business, the U.S. primarily focuses on research in the fields of proteomics, drug screening and discovery, and genomic structure prediction. The synthetic biology market is expected to grow at the fastest rate in the Asia Pacific region, which is expected to be fueled by factors such as rising investments in Asia Pacific nations, expanding partnerships & funding in the Chinese market, and expanding collaborations in the field of synthetic biology
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Synthetic Biology Market Segmentation
By Technology
By Product Type
- Synthetic DNA,
- XNA,
- Chassis Organism
By Application
- Chemicals,
- Pharmaceuticals,
- Biopharmaceuticals,
- Agriculture,
- Others
Frequently Asked Questions
The Synthetic Biology Market size was valued at USD 9.4 billion in 2023
Asia Pacific is the fastest-growing for synthetic biology market
The synthetic biology market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1.Executive Summary |
| 2.Global Synthetic Biology Market Introduction |
| 2.1.Global Synthetic Biology Market - Taxonomy |
| 2.2.Global Synthetic Biology Market - Definitions |
| 2.2.1.Technique |
| 2.2.2.Preservation |
| 2.2.3.End-User |
| 2.2.4.Region |
| 3.Global Synthetic Biology Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Synthetic Biology Market Analysis, 2019-2023 and Forecast 2024-2030 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Synthetic Biology Market By Technique, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 5.1. Enabled Products |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Enabling Products |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Synthetic Biology Market By Preservation, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 6.1. Synthetic DNA, |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. XNA, |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Chassis Organism |
| 6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Synthetic Biology Market By End-User, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 7.1. Chemicals, |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Pharmaceuticals, |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Biopharmaceuticals, |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Agriculture, |
| 7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.Global Synthetic Biology Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Synthetic Biology Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 9.1. Technique Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Enabled Products |
| 9.1.2.Enabling Products |
| 9.2. Preservation Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Synthetic DNA, |
| 9.2.2.XNA, |
| 9.2.3.Chassis Organism |
| 9.3. End-User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Chemicals, |
| 9.3.2.Pharmaceuticals, |
| 9.3.3.Biopharmaceuticals, |
| 9.3.4.Agriculture, |
| 9.3.5.Others |
| 9.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Synthetic Biology Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 10.1. Technique Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Enabled Products |
| 10.1.2.Enabling Products |
| 10.2. Preservation Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Synthetic DNA, |
| 10.2.2.XNA, |
| 10.2.3.Chassis Organism |
| 10.3. End-User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Chemicals, |
| 10.3.2.Pharmaceuticals, |
| 10.3.3.Biopharmaceuticals, |
| 10.3.4.Agriculture, |
| 10.3.5.Others |
| 10.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 10.4.7. |
| 11.Asia Pacific (APAC) Synthetic Biology Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 11.1. Technique Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Enabled Products |
| 11.1.2.Enabling Products |
| 11.2. Preservation Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Synthetic DNA, |
| 11.2.2.XNA, |
| 11.2.3.Chassis Organism |
| 11.3. End-User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Chemicals, |
| 11.3.2.Pharmaceuticals, |
| 11.3.3.Biopharmaceuticals, |
| 11.3.4.Agriculture, |
| 11.3.5.Others |
| 11.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Synthetic Biology Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 12.1. Technique Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Enabled Products |
| 12.1.2.Enabling Products |
| 12.2. Preservation Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Synthetic DNA, |
| 12.2.2.XNA, |
| 12.2.3.Chassis Organism |
| 12.3. End-User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Chemicals, |
| 12.3.2.Pharmaceuticals, |
| 12.3.3.Biopharmaceuticals, |
| 12.3.4.Agriculture, |
| 12.3.5.Others |
| 12.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Synthetic Biology Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 13.1. Technique Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Enabled Products |
| 13.1.2.Enabling Products |
| 13.2. Preservation Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Synthetic DNA, |
| 13.2.2.XNA, |
| 13.2.3.Chassis Organism |
| 13.3. End-User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Chemicals, |
| 13.3.2.Pharmaceuticals, |
| 13.3.3.Biopharmaceuticals, |
| 13.3.4.Agriculture, |
| 13.3.5.Others |
| 13.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Agilent Technologies (U.S.) |
| 14.2.2.Thermo Fisher Scientific Inc. (U.S.) |
| 14.2.3.GEN9 Inc. (U.S.) |
| 14.2.4.Novozymes |
| 14.2.5.Amyris Biotechnologies (U.S.) |
| 14.2.6.Merck KGaA (Germany) |
| 14.2.7.Epoch Life Science Inc. (U.S.) |
| 14.2.8.Intrexon Corporation (U.S.) |
| 14.2.9.Gevo Inc. (U.S.) |
| 14.2.10.Gingko Bioworks (U.S) |
| 14.2.11.Twist Bioscience |
| 14.2.12.GenScript |
| 14.2.13.Integrated DNA Technologies, Inc. |
| 14.2.14.Synthetic Genomics Inc. |
| 14.2.15.New England Biolabs |
| 14.2.16.Sangamo Therapeutics, Inc. (U.S.) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Agilent Technologies (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- GEN9 Inc. (U.S.)
- Novozymes
- Amyris Biotechnologies (U.S.)
- Merck KGaA (Germany)
- Epoch Life Science Inc. (U.S.)
- Intrexon Corporation (U.S.)
- Gevo Inc. (U.S.)
- Gingko Bioworks (U.S)
- Twist Bioscience
- GenScript
- Integrated DNA Technologies, Inc.
- Synthetic Genomics Inc.
- New England Biolabs
- Sangamo Therapeutics, Inc. (U.S.)